Q32 Bio
QTTB
QTTB
71 hedge funds and large institutions have $15.5M invested in Q32 Bio in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
59% less capital invested
Capital invested by funds: $37.8M → $15.5M (-$22.3M)
69% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 26
88% less call options, than puts
Call options by funds: $1K | Put options by funds: $8K
Holders
71
Holding in Top 10
3
Calls
$1K
Puts
$8K
Top Buyers
| 1 | +$68.1K | |
| 2 | +$50K | |
| 3 | +$42.8K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$36.2K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.8K |
Top Sellers
| 1 | -$2.4M | |
| 2 | -$1.08M | |
| 3 | -$280K | |
| 4 |
Two Sigma Investments
New York
|
-$183K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$173K |
